Announcing a new article publication for Zoonoses journal. Vaccinia virus (VACV) confers cross-protective immunity against ...

North America preventive vaccines market is projected to grow by 6.3% annually in the forecast period and reach $46.90 billion by 2032, driven by the rising prevalence of several ...

Request To Download Free Sample of This Strategic Report @ Highlighted with 62 tables and 55 figures, this 142-page report ?Europe Preventive Vaccines Market 2022-2032 by Vaccine Type, Disease, ...

Despite decades of efforts, tuberculosis remains a global health crisis, claiming over 1.3 million lives annually.

Feb. 5, 2025 — Researchers report that all nine patients in a clinical trial being treated for stage III or IV clear cell renal cell carcinoma (a form of kidney cancer), generated a successful ...

The first participants have been vaccinated with an investigational Ebola Sudan vaccine candidate provided by IAVI, a nonprofit scientific ...

Recombinant antibodies help study immune responses and evaluate vaccine efficacy. In this way, they contribute to the rapid development of vaccines against complex infectious diseases like COVID-19.

A total of twenty-five mice were randomly divided into five groups to evaluate the immunogenicity of the recombinant HSV-vector-based SIV vaccine. During the initial week, each mouse was ...

Fortress Biotech and its subsidiary Helocyte have announced the dosing of the first subject in a multi-centre Phase II trial ...

Jcovden Market Report 2025 – Market Size, Trends, And Forecast 2025-2034 The Business Research Company’s Jcovden Global Market Report 2025 – Market Size, Trends, And Forecast 2025-2034 Updated ...